| 1 |
Ali N, Srivastava N. Recent Advancements for the Management of Pancreatic Cancer: Current Insights. CCTR 2021;17:267-82. [DOI: 10.2174/1573394717666210625153256] [Reference Citation Analysis]
|
| 2 |
Muñoz R, Girotti A, Hileeto D, Arias FJ. Metronomic Anti-Cancer Therapy: A Multimodal Therapy Governed by the Tumor Microenvironment. Cancers (Basel) 2021;13:5414. [PMID: 34771577 DOI: 10.3390/cancers13215414] [Reference Citation Analysis]
|
| 3 |
Cao PW, Liu L, Li ZH, Cao F, Liu FB. Prognostic Value of Drug Targets Predicted Using Deep Bioinformatic Analysis of m6A-Associated lncRNA-Based Pancreatic Cancer Model Characteristics and Its Tumour Microenvironment. Front Genet 2022;13:853471. [PMID: 35547245 DOI: 10.3389/fgene.2022.853471] [Reference Citation Analysis]
|
| 4 |
Yu S, Zhang C, Xie KP. Therapeutic resistance of pancreatic cancer: Roadmap to its reversal. Biochim Biophys Acta Rev Cancer 2021;1875:188461. [PMID: 33157162 DOI: 10.1016/j.bbcan.2020.188461] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Liu G, Wang M, He H, Li J. Doxorubicin-Loaded Tumor-Targeting Peptide-Decorated Polypeptide Nanoparticles for Treating Primary Orthotopic Colon Cancer. Front Pharmacol 2021;12:744811. [PMID: 34721033 DOI: 10.3389/fphar.2021.744811] [Reference Citation Analysis]
|
| 6 |
Qiu R, Sun D, Bai Y, Li J, Wang L. Application of tumor-targeting peptide-decorated polypeptide nanoparticles with doxorubicin to treat osteosarcoma. Drug Deliv 2020;27:1704-17. [PMID: 33305647 DOI: 10.1080/10717544.2020.1856221] [Reference Citation Analysis]
|
| 7 |
Sun Y, Liu Y, Ma X, Hu H. The Influence of Cell Cycle Regulation on Chemotherapy. Int J Mol Sci 2021;22:6923. [PMID: 34203270 DOI: 10.3390/ijms22136923] [Reference Citation Analysis]
|
| 8 |
Hu X, Xiao Y, Sun J, Ji B, Luo S, Wu B, Zheng C, Wang P, Xu F, Cheng K, Hua H, Li D. New possible silver lining for pancreatic cancer therapy: Hydrogen sulfide and its donors. Acta Pharm Sin B 2021;11:1148-57. [PMID: 34094825 DOI: 10.1016/j.apsb.2020.10.019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 9 |
Debele TA, Yeh CF, Su WP. Cancer Immunotherapy and Application of Nanoparticles in Cancers Immunotherapy as the Delivery of Immunotherapeutic Agents and as the Immunomodulators. Cancers (Basel) 2020;12:E3773. [PMID: 33333816 DOI: 10.3390/cancers12123773] [Reference Citation Analysis]
|
